Published in Law and Health Weekly, August 9th, 2008
The closing of this offering is expected to take place on July 25, 2008. Proceeds from the transaction will be used in the further development of Optimer's ongoing programs, as well as for other general corporate purposes.
Copies of the final prospectus supplement and accompanying base prospectus can be obtained from the Corporate Communications Manager, Optimer Pharmaceuticals,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly